Event
Date: March 24, 2020
Location: Regenstrief Institute, 1101 W. 10th St., Indianapolis, IN 46202

2020 LOINC Conference – Indianapolis

LOINC 2020 Indy Meeting

In-person workshops for March 25 have been cancelled for this event. Committee meetings on March 24 and 26 will be online only.

Join LOINCers from around the globe at this special event featuring informative presentations and—for the first time in the U.S.—both the Laboratory LOINC Committee and Clinical LOINC Committee meetings.

This event will be held at LOINC’s home, Regenstrief Institute in Indiana. Our beautiful facility is the ideal location for three days of learning, collaboration, and networking.

DAY 1: MARCH 24 – Laboratory Committee Meeting
The Laboratory LOINC Committee convenes on the first day of the conference to hear updates on LOINC adoption and discuss key issues for development and implementation. All are welcome! You may attend as part of the conference or separately at no cost. Remote attendance is also available.

DAY 2: MARCH 25 – Educational Workshops & Presentations
We’re excited to offer a range of hands-on training sessions, with each one led by top LOINCers and implementers. Review the entire schedule and find the options that best fits your needs. During registration, you will select the sessions you plan to attend.

DAY 3: MARCH 26 – Clinical Committee Meeting
The Clinical LOINC Committee will meet on the final day of the conference. Hear updates and issues related to the clinical domain. All committee meetings are open to the public and free. Remote attendance is available for this event as well.

Registration deadline is March 19!

LEARN MORE & REGISTER

Related News

Johanne Eliacin and Sophia Wang

Factors influencing participation of Black and White Americans in Alzheimer’s disease biomarker research

Regenstrief researcher leads study of barriers to participation and drivers of engagement The use of Alzheimer’s disease (AD) biomarkers

Multi-state study reports COVID-19 mRNA vaccines protective during Omicron BA.4/BA.5 predominance

Multi-state study reports COVID-19 mRNA vaccines protective during Omicron BA.4/BA.5 predominance

Study also finds less severe disease during BA.4/BA.5 predominance compared to earlier Omicron variants A multi-state study from the

Dr. Kurt Kroenke at the 2023 Indianapolis Business Journal's Health Care Heroes Awards Breakfast

IBJ Honors Regenstrief research scientist with Heath Care Hero Award 

The Indianapolis Business Journal (IBJ) honored Regenstrief Research Scientist Kurt Kroenke, M.D., MACP, as a Health Care Hero at

LOINC Logo

LOINC 2.74 Release Webinar scheduled for spring 2023

LOINC® from Regenstrief Institute will host an educational webinar for the February 2023 2.74 release of new concepts, scheduled